Selective Estrogen Receptor Modulators and Aromatase Inhibitors for Breast Cancer Chemoprevention

E-ISSN： 1873-5592|12|13|1874-1887

ISSN： 1389-4501

Source： Current Drug Targets, Vol.12, Iss.13, 2011-12, pp. : 1874-1887

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recent Advances in Selective Estrogen Receptor Modulators for Breast Cancer

Mini Reviews in Medicinal Chemistry, Vol. 9, Iss. 10, 2009-09 ,pp. : 1191-1201

Bentham Science Publishers

Access to resources Recommend Favorite

The First Organometallic Selective Estrogen Receptor Modulators (SERMs) and Their Relevance to Breast Cancer

Current Medicinal Chemistry, Vol. 11, Iss. 18, 2004-09 ,pp. : 2505-2517

Bentham Science Publishers

Access to resources Recommend Favorite

Comparative Tolerability of First-Generation Selective Estrogen Receptor Modulators in Breast Cancer Treatment and Prevention

By Curtis M.G.

Drug Safety, Vol. 24, Iss. 14, 2001-01 ,pp. : 1039-1053

Adis International

Access to resources Recommend Favorite

Recent Advancement in Nonsteroidal Aromatase Inhibitors for Treatment of Estrogen-Dependent Breast Cancer

Current Medicinal Chemistry, Vol. 17, Iss. 30, 2010-10 ,pp. : 3476-3487

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacokinetics of Selective Estrogen Receptor Modulators

By Morello K.C. Wurz G.T. DeGregorio M.W.

Clinical Pharmacokinetics, Vol. 42, Iss. 4, 2003-01 ,pp. : 361-372

Adis International

Access to resources Recommend Favorite